Skip to main content

Hypertension and Pregnancy

  • Chapter
  • First Online:
Evidence-Based Cardiology Consult

Abstract

Hypertension is the most common medical disorder encountered during pregnancy, affecting up to 10 % of all pregnancies. Hypertensive disorders are one of the major causes of pregnancy-related maternal deaths in the United States. Hypertension in pregnancy includes a spectrum of conditions, including preeclampsia-eclampsia, preeclampsia superimposed on chronic hypertension, chronic hypertension, and gestational hypertension. Unlike other hypertensive pregnancy disorders, preeclampsia is a multisystem disease, its distinctive feature being either sudden onset or worsening of preexisting proteinuria. Despite significant advances in our understanding of preeclampsia, the etiology of this condition remains elusive, resulting in a failure to develop specific screening, preventive, and treatment strategies. Delivery remains the mainstay of therapy for severe forms and anticipated life-threatening complications. The most important reason for the initiation of antihypertensive treatment in these patients is to prevent maternal cerebrovascular and cardiac complications. The optimal timing and choice of therapy for hypertensive pregnancy disorders involves carefully weighing the risk-versus-benefit ratio for each individual patient, with an overall goal of improving maternal and fetal outcomes. Finally, over the past decades, it has become increasingly clear that women with a history of preeclamptic compared to normotensive pregnancies are at increased risk for cardiovascular disease later in life. In this chapter, we summarize the mechanisms thought to be involved in hypertensive pregnancy disorders, review the current treatment guidelines, and outline some newer perspectives on management, including postpartum monitoring and treatment of conventional cardiovascular risk factors in the affected women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anonymous. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–22 [comment].

    Google Scholar 

  2. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533–8.

    Article  PubMed  CAS  Google Scholar 

  3. Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol. 2007;3:613–22.

    Article  PubMed  Google Scholar 

  4. Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb JD, Mosley TH, Wiste JW, Turner ST. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28:826–33.

    Article  PubMed  CAS  Google Scholar 

  5. McLaughlin M, Roberts JM. Hemodynamic changes. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley’s hypertensive disorders in pregnancy. Stamford: Appleton & Lange; 1999. p. 69–102.

    Google Scholar 

  6. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16:5–15.

    Article  PubMed  CAS  Google Scholar 

  7. Ramsey EM. The story of the spiral arteries. J Reprod Med. 1981;26:393–9.

    PubMed  CAS  Google Scholar 

  8. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 1991;98:648–55.

    Article  PubMed  CAS  Google Scholar 

  9. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol. 2002;187:1416–23.

    Article  PubMed  Google Scholar 

  10. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93:1049–59.

    Article  PubMed  CAS  Google Scholar 

  11. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994;101:669–74.

    Article  PubMed  CAS  Google Scholar 

  12. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669–72.

    Article  PubMed  CAS  Google Scholar 

  13. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–83 [see comment].

    Article  PubMed  CAS  Google Scholar 

  14. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–58 [see comment].

    PubMed  CAS  Google Scholar 

  15. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007;109:168–80.

    Article  PubMed  CAS  Google Scholar 

  16. Garovic VD, Wagner SJ, Petrovic LM, Gray CE, Hall P, Sugimoto H, Kalluri R, Grande JP. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant. 2007;22:1136–43.

    Article  PubMed  CAS  Google Scholar 

  17. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196:320.e321–7 [see comment].

    Article  Google Scholar 

  18. Steegers EA, Eskes TK, Jongsma HW, Hein PR. Dietary sodium restriction during pregnancy; a historical review. Eur J Obstet Gynecol Reprod Biol. 1991;40:83–90.

    Article  PubMed  CAS  Google Scholar 

  19. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1998;338:701–5.

    Article  PubMed  CAS  Google Scholar 

  20. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp Jr JM, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282–91.

    Article  PubMed  CAS  Google Scholar 

  21. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, Clemens JD, Cutler JA. Trial of calcium to prevent preeclampsia. N Engl J Med. 1997;337:69–76.

    Article  PubMed  CAS  Google Scholar 

  22. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988;95:120–5.

    Article  PubMed  CAS  Google Scholar 

  23. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159–67.

    PubMed  CAS  Google Scholar 

  24. Wagner SJ, Craici IM, Hogan MC, Bailey KR, Garovic VD. The effect of early diagnosis and treatment on maternal and fetal outcomes in patients with HELLP syndrome. Biochem Med. 2007;17:60–70.

    Google Scholar 

  25. Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;CD000025.

    Google Scholar 

  26. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;CD002252

    Google Scholar 

  27. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol. 2000;96:849–60.

    Article  PubMed  CAS  Google Scholar 

  28. August P. Preeclampsia: new thoughts on an ancient problem. J Clin Hypertens. 2000;2:115–23.

    Google Scholar 

  29. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ace inhibitors. N Engl J Med. 2006;354:2443–51.

    Article  PubMed  CAS  Google Scholar 

  30. Gant NF, Madden JD, Siteri PK, MacDonald PC. The metabolic clearance rate of dehydroisoandrosterone sulfate. III. The effect of thiazide diuretics in normal and future pre-eclamptic pregnancies. Am J Obstet Gynecol. 1975;123:159–63.

    PubMed  CAS  Google Scholar 

  31. Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. Br Med J. 1985;290:17–23.

    Article  CAS  Google Scholar 

  32. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92.

    Article  Google Scholar 

  33. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the united states, 1998–2005. Obstet Gynecol. 2010;116:1302–9.

    Article  PubMed  Google Scholar 

  34. Martin Jr JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246–54.

    Article  PubMed  Google Scholar 

  35. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.

    Article  PubMed  CAS  Google Scholar 

  36. Wagner SJ, Acquah L, Lindell E, Craici I, Wingo M, Rose C, White W, August P, Garovic V. Posterior reversible encephalopathy syndrome (PRES) and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc. 2011;86(9):851–6.

    Article  PubMed  Google Scholar 

  37. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–32.

    Article  PubMed  Google Scholar 

  38. Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007;50:14–24.

    Article  PubMed  CAS  Google Scholar 

  39. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4:42–50.

    Article  PubMed  CAS  Google Scholar 

  40. Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the value trial. Lancet. 2004;363:2049–51.

    Article  PubMed  CAS  Google Scholar 

  41. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974 [see comment].

    Article  PubMed  Google Scholar 

  42. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am J Obstet Gynecol. 2004;190:714–20.

    Article  PubMed  Google Scholar 

  43. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D’Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update. Circulation. 2011;123:1243–62.

    Article  PubMed  Google Scholar 

  44. Garovic VD. The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension. Hypertension. 2012;59(3):555–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vesna D. Garovic MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Acquah, L., Garovic, V.D. (2014). Hypertension and Pregnancy. In: Stergiopoulos, K., Brown, D. (eds) Evidence-Based Cardiology Consult. Springer, London. https://doi.org/10.1007/978-1-4471-4441-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4441-0_30

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4440-3

  • Online ISBN: 978-1-4471-4441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics